These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17308089)

  • 1. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells.
    Compton SA; Choi JH; Cesare AJ; Ozgür S; Griffith JD
    Cancer Res; 2007 Feb; 67(4):1513-9. PubMed ID: 17308089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ku suppresses formation of telomeric circles and alternative telomere lengthening in Arabidopsis.
    Zellinger B; Akimcheva S; Puizina J; Schirato M; Riha K
    Mol Cell; 2007 Jul; 27(1):163-9. PubMed ID: 17612498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
    Jiang WQ; Zhong ZH; Henson JD; Neumann AA; Chang AC; Reddel RR
    Mol Cell Biol; 2005 Apr; 25(7):2708-21. PubMed ID: 15767676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres.
    Zhong ZH; Jiang WQ; Cesare AJ; Neumann AA; Wadhwa R; Reddel RR
    J Biol Chem; 2007 Oct; 282(40):29314-22. PubMed ID: 17693401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to telomerase: keeping linear chromosomes via telomeric circles.
    Tomaska L; McEachern MJ; Nosek J
    FEBS Lett; 2004 Jun; 567(1):142-6. PubMed ID: 15165907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere uncapping and alternative lengthening of telomeres.
    Cesare AJ; Reddel RR
    Mech Ageing Dev; 2008; 129(1-2):99-108. PubMed ID: 18215414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length homeostasis requires that telomerase levels are limiting.
    Cristofari G; Lingner J
    EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
    Sun B; Chen M; Hawks CL; Hornsby PJ
    Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.